[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 1973

The Clinical Pharmacology of ImipramineImplications for Therapeutics

Author Affiliations

New York
From the New York State Psychiatric Institute and the Department of Psychiatry, Columbia University, College of Physicians and Surgeons, New York.

Arch Gen Psychiatry. 1973;28(5):649-653. doi:10.1001/archpsyc.1973.01750350029006
Abstract

In the last several years it has become apparent that identical oral doses of a tricyclic antidepressant can, in different individuals, result in radically different blood levels. This phenomenon which is the result of drug-drug interactions and individual genetic characteristics has major clinical implications. The plasma level resulting from a standard oral dose can be markedly increased or decreased by the concomitant administration of numerous usually used medications. This is a significant and commonly unrecognized problem and compounds the genetic metabolic variability inherent in these drugs.

In this review imipramine hydrochloride is used as a model for the tricyclic antidepressants in general. Its metabolism and pharmacodynamics are examined with specific emphasis on their relationship to the marked individual variability seen in this class of drugs and the relationship of this variability to clinical effectiveness.

×